Anti-CD19 CAR / NFAT (Luciferase) Reporter Jurkat Cell Line (CD19 SCFV-CD28-4-1BB-CD3?)

Product Code
AMS.79853
$12,065.00
Order Support
Shipping Information
Product Updates
  • Keep up to date with product offers, resources and news

  • Sign up

Anti-CD19 CAR/NFAT-luciferase reporter Jurkat cell line is a double stable cell line expressing anti-CD19 CAR and NFAT-luciferase reporter. It is made from the anti-CD19 CAR lentivirus ( Bioscience #79851). The reporter cell line has been validated for anti CD19-CAR expression by FACS, and for luciferase reporter activation stimulated by target cells including CD19/CHO recombinant cell line can be used for primary screening and functional validation of anti-CD19 CAR construct and lentivirus before testing in primary T cells.

Anti-CD19 CAR consists of anti-CD19 scFv linked to 3rd generation CAR (Chimeric Antigen Receptor) containing CD28, 4-1BB co-stimulatory domains, and CD3? signaling domain.
More Information
SKU AMS.79853
Size 2 vials
Application • Validate different CAR designs and constructs for their specificity, efficacy and potency before proceeding into patient-derived primary T cells.
• Predict the Mechanism of Action (MOA) of CAR.
• Intracellular co-stimulatory and activati
Storage Immediately upon receipt, store in liquid nitrogen.
Shipping Temp -80C
Supplier Name BPS